Apheresis Equipment Market Set to Witness an Uptick during 2018 to 2024
The global apheresis
equipment market size is expected
to reach USD 3.7 billion by 2024,
according to a new report by Grand View Research, Inc. The apheresis equipment
industry is expected to be impacted by factors such as rising demand for
plasma, platelets and other blood components, increasing incidence of chronic
illnesses, presence and development of ideal reimbursement policies across
various regions, and supportive government initiatives.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
The U.S. Federal Government has been
very involved in the funding of apheresis research through its benefit programs
such as Medicare, Medicaid, veterans’ health administration military and
employee insurance programs. Medicare provides coverage for apheresis
regardless of whether the procedure is performed in a hospital or a blood
center. In addition, private insurers have recently begun to closely examine
apheresis procedures and issue policy statements pertaining to coverage.
Growing incidence of blood related
disorders leading to the rise in demand for platelets and plasma is expected to
serve the market as a high impact rendering driver. The industry is also
expected to be driven by technology innovations aimed at delivering relatively
more effective and faster results. Healthcare practitioners and researchers are
now in the need for devices requiring minimum human intervention and
introduction of fully automatic apheresis equipment with enhanced displays is
expected to improve usage rates.
To Request Sample Copy of this report, click the link:
Further Key Findings From the Study
Suggest:
·
Disposable apheresis kits are
anticipated to dominate the product segment by 2024. Bulk volume purchase
associated with these products is predicted to govern their growth.A single
cycle of apheresis procedure consumes multiple disposable sub parts which is
responsible for comparatively larger market volume as compared to apheresis
machines.
·
The photopheresis procedure is
anticipated to witness lucrative growth owing to its rising demand in
treatment. The procedure is approved for treatment of solid organ transplant
rejection, scleroderma, type 1 diabetes, pemphigus vulgaris, lichen planus
&atopic dermatitis, and cutaneous T-cell lymphoma.
·
Another procedure expected to
gain lucrative share is erythrocytapheresis. The procedure also finds
application in blood donation procedures where it is widely used for separating
two units of blood, known as double red cell apheresis. Rising incidence rates
of genetic disorders such as sickle cell anemia is expected to drive apheresis
equipment market growth by widening the patient base.
·
Asia Pacific is anticipated to
witness the fastest growth over the forecast period. Presence of high unmet
needs and rapidly increasing demand for platelets in the emerging Asia Pacific
and Latin American markets is expected to serve this market as future growth
opportunities. For example, in July, 2014, India witnessed a rapid rise in
demand for platelets owing to an increased incidence rate of dengue.
·
Key players of this industry
include Fresenius Kabi; Haemonetics; Terumo BCT; Therakos, Inc.; Asahi Kasei
Kuraray Medical Co Ltd; and B. Braun Melsungen AG. Strategies promoting faster
distribution and development of efficient supply chain are being incorporated
by the players.
·
For instance, in March 2014,
Therakos, Inc., signed an exclusive distribution agreement with Terumo BCT,
wherein Terumo would be the sole supplier of UVAR XTS and THERAKOS CELLEX in
the Latin American region. Countries such as Mexico, Argentina, Peru, Colombia
and Uruguay would be under purview.
The
global apheresis equipment market size was valued at USD 1,395.9 million in
2015 and is expected to reach USD 3,732.6 million in 2024, growing at a CAGR of
11.5% during the forecast period. Presence of favorable government initiatives
and reimbursement framework is expected to boost demand during the forecast
period.
Furthermore,
rise in the number of platelet donors and R&D investments by
biopharmaceutical companies are expected to serve as high impact rendering
drivers.
Rising
incidence of blood-related disorders is expected to boost demand by increasing
the usage rates of apheresis machines and kits. According to the NHSBT the
demand for platelets is expected to grow at a rate of 3% annually from 2011 to
2014. Moreover, growing awareness levels pertaining to platelet donation is
anticipated to support demand in developed economies.
Product Insights
Kits are bundled together and are
inclusive of filters, separators, tubing set, and other components. High usage
volume coupled with rapidly growing demand for apheresis procedures are some
factors attributing to its large share. In addition, single usage helps in
limiting device-related blood infections in donors and patients, thereby
boosting segment growth.
Procedure Insights
Plasmapheresis accounted for the
largest share of about 50.0% of the overall procedure market in 2015.
Plasmapheresis developed in 1951 by Grifols is a procedure involving the
separation of plasma from blood cells. Plasma-based drugs are also administered
to patients with weak immune systems in an attempt to increase resistance to
infection/disease. Rising incidence of blood-related disorders and growing
demand for plasma-derived medicines is expected to serve as a primary growth
driver.
Browse
Press Release of this report:
Grand View Research has segmented the
global apheresis equipment market on the basis of product, application,
procedure, technology.
Apheresis Equipment By Product , 2013 - 2024 (USD
Million)
·
Disposable apheresis kits
·
Apheresis machine
Apheresis Equipment By Application , 2013 - 2024 (USD
Million)
·
Renal diseases
·
Hematology
·
Neurology
·
Others
Apheresis Equipment By Procedure , 2013 - 2024 (USD
Million)
·
Plasmapheresis
·
LDL-apheresis
·
Plateletpheresis
·
Leukapheresis
·
Photopheresis
·
Erythrocytapheresis
·
Others
Apheresis Equipment By Technology , 2013 - 2024 (USD
Million)
·
Membrane Filtration
·
Centrifugation
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment